Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation.
Wittner M, Dunay GA, Kummer S, Bockhorn M, Hüfner A, Schmiedel S, Degen O, van Lunzen J, Eberhard JM, Schulze Zur Wiesch J. Wittner M, et al. Among authors: bockhorn m. J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):345-349. doi: 10.1097/QAI.0000000000001622. J Acquir Immune Defic Syndr. 2018. PMID: 29293157
p53 overexpression is a prognosticator of poor outcome in esophageal cancer.
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F. Melling N, et al. Among authors: bockhorn m. Oncol Lett. 2019 Apr;17(4):3826-3834. doi: 10.3892/ol.2019.10020. Epub 2019 Feb 6. Oncol Lett. 2019. PMID: 30881503 Free PMC article.
The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist YK, Kutup A, Musici S, Yekebas EF, Mina S, Uzunoglu G, Zehler O, Koenig A, Cataldegirmen G, Bockhorn M, Effenberger K, Kalinin V, Pantel K, Izbicki JR. Vashist YK, et al. Among authors: bockhorn m. Cell Oncol (Dordr). 2011 Aug;34(4):281-8. doi: 10.1007/s13402-011-0016-x. Epub 2011 Feb 22. Cell Oncol (Dordr). 2011. PMID: 21340746
Aberrant expression of Sec61α in esophageal cancers.
Bachmann K, Bockhorn M, Mann O, Gebauer F, Blessmann M, Izbicki JR, Grupp K. Bachmann K, et al. Among authors: bockhorn m. J Cancer Res Clin Oncol. 2019 Aug;145(8):2039-2044. doi: 10.1007/s00432-019-02955-7. Epub 2019 Jun 13. J Cancer Res Clin Oncol. 2019. PMID: 31197453
FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.
Grupp K, Uzunoglu FG, Melling N, Hofmann B, El Gammal AT, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki JR, Kutup A. Grupp K, et al. Among authors: bockhorn m. Sci Rep. 2018 Nov 26;8(1):17370. doi: 10.1038/s41598-018-35459-4. Sci Rep. 2018. PMID: 30478420 Free PMC article.
Loss of 4q21.23-22.1 is a prognostic marker for disease free and overall survival in non-small cell lung cancer.
Uzunoglu FG, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist YK, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki JR, Wikman H. Uzunoglu FG, et al. Among authors: bockhorn m. PLoS One. 2014 Dec 11;9(12):e113315. doi: 10.1371/journal.pone.0113315. eCollection 2014. PLoS One. 2014. PMID: 25501003 Free PMC article.
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl FR, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki JR, Lohse AW, Schrader J. Benten D, et al. Among authors: bockhorn m. Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12. Mol Cancer Res. 2018. PMID: 29330294
182 results